1614.85 -2.20 (-0.14%)
NSEJan 20, 2021 02:09 PM
Latest broker research reports with buy, sell, hold recommendations along with forecast target prices and upside. Browse thousands of reports and search by company or the broker.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2019-11-11||BASF India Ltd. +||Emkay||990.35||1115.00||990.35 (63.06%)||Target met||Hold|
Q2FY20 revenues were above our estimates, mainly due to a change in revenue recognition model. Revenue was up 24% yoy to Rs20.7bn (our est. of Rs17.5bn). EBITDA stood at Rs761mn vs. our est. of Rs669mn. Strong growth in Agriculture solutions (+17%), Industrial Solution (+10%) and Nutrition & Care (+82%) segments was partially offset by its Materials segment (-7%). The company has switched to a merchandise business model from an agency business model, due to which, the Chemicals segment revenues jumped eightfold yoy to Rs3.1bn. 166bps/189bps yoy while the Nutrition & care segment and Surface Technologies segments...